• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Restricted Flow rate (1248)
Patient Problems Ischemia (1942); Paresis (1998)
Event Type  Injury  
Event Description
Information received from the article: keskin et al.Endovascular treatment of complex intracranial aneurysms by pipeline flow-diverter embolization device: a single-center experience.Neurological research.2015;37(4): 359-365.Medtronic (covidien) received information through literature review regarding adverse events and the manufactured products involved with them.Twenty-four patients (mean age 50, 14 female) were treated between april 2012 and december 2013.One patient with a vertebrobasilar aneurysm had 4 overlapping pipelines placed and developed a small ischemic area in the anterior surface of the medulla oblongata probably due to perforating vessel obstruction covered by the ped.The patient deteriorated at postoperative fourth hour and developed left sided hemiplegia.The patient is currently stable without any additional deterioration.One patient stopped taking antiplatelet therapy against medical advice at 2 months and the pipeline became occluded.The patient had no symptoms and antiplatelet therapy was not prescribed again.The patient has been under follow-up for 22 months without any problems.The article concludes that treatment of vertebrobasilar fusiform aneurysms via the pipeline poses some difficulties due primarily to complex structure of these aneurysms.During this review and study, parent artery reconstruction via flow diversion with the pipeline embolization device is a valid and safe form of treatment with low morbidity for wide necked complex aneurysms and also the aneurysms which are not amenable for standard coiling procedures including small aneurysms.
 
Manufacturer Narrative
The report was created to capture the complications from the review in the article: keskin et al.Endovascular treatment of complex intracranial aneurysms by pipeline flow-diverter embolization device: a single-center experience.Neurological research.2015;37(4): 359-365.The lot history review was not possible as the lot numbers were not reported.The devices involved in the event will not be returned for evaluation as they were implanted in the patient.
 
Manufacturer Narrative
Corrected to serious injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key4553861
MDR Text Key22066075
Report Number2029214-2015-00211
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeTU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/30/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/27/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/30/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient Age50 YR
-
-